Skip to Content



Definition: An antagonist of the smoothened (i.e., SMO) receptor, part of the hedgehog signaling pathway used in treating advanced basal cell carcinoma.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.